NO913127L - Fremgangsmaate for fremstilling av noeytraliserende hiv-determinanter. - Google Patents

Fremgangsmaate for fremstilling av noeytraliserende hiv-determinanter.

Info

Publication number: NO913127L
Authority: NO; Norway
Prior art keywords: procedure; manufacturing; neutralizing hiv; determinants; hiv determinants
Prior art date: 1990-08-13

Application number

NO91913127A

Other languages

English (en)

Other versions

NO913127D0 (no

Inventor

John A Lewis

Joseph P Davide

Julie Ann Waterbury

Original Assignee

Merck & Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-08-13

Filing date

1991-08-12

Publication date

1992-02-14

1991-08-12 Application filed by Merck & Co Inc filed Critical Merck & Co Inc

1991-08-12 Publication of NO913127D0 publication Critical patent/NO913127D0/no

1992-02-14 Publication of NO913127L publication Critical patent/NO913127L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Mycology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Hematology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Oncology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO91913127A 1990-08-13 1991-08-12 Fremgangsmaate for fremstilling av noeytraliserende hiv-determinanter. NO913127L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US56665690A	1990-08-13	1990-08-13
US56665490A	1990-08-13	1990-08-13
US56663890A	1990-08-13	1990-08-13

Publications (2)

Publication Number	Publication Date
NO913127D0 NO913127D0 (no)	1991-08-12
NO913127L true NO913127L (no)	1992-02-14

Family

ID=27415998

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO91913127A NO913127L (no)	1990-08-13	1991-08-12	Fremgangsmaate for fremstilling av noeytraliserende hiv-determinanter.

Country Status (11)

Country	Link
EP (1)	EP0471407A3 (no)
JP (1)	JPH06321808A (no)
KR (1)	KR920004422A (no)
AU (1)	AU642751B2 (no)
CA (1)	CA2048594A1 (no)
FI (1)	FI913817A (no)
IE (1)	IE912846A1 (no)
IL (1)	IL99077A0 (no)
NO (1)	NO913127L (no)
NZ (1)	NZ239281A (no)
PT (1)	PT98633A (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0519554A1 (en) *	1991-06-19	1992-12-23	Merck & Co. Inc.	Conjugates of the class II protein of the outer membrane of neisseria meningitidis and of HIV-1 related peptides
US5556744A (en) *	1992-05-29	1996-09-17	The Trustees Of The University Of Pennsylvania	Methods and compositions for diagnosing and treating certain HIV infected patients
GB2282380A (en) *	1993-09-30	1995-04-05	Merck & Co Inc	Conjugate of epitopes of HIV with a protein complex from Neisseria
GB2282378A (en) *	1993-09-30	1995-04-05	Merck & Co Inc	Conjugates of epitopes of HIV with a protein complex from Neisseria
DE59510092D1 (de) *	1994-07-25	2002-04-11	Roche Diagnostics Gmbh	Hapten-markierte peptide
GB2294047A (en) *	1994-10-14	1996-04-17	Merck & Co Inc	Synthetic peptides for use as epitopes specific for HIV
ES2293643T5 (es) *	1994-10-20	2012-02-02	Institut Pasteur	Secuencias nucleotídicas de antígenos retrovíricos vih-1 del grupo (o subgrupo) o.
FR2731225B1 (fr) *	1995-03-03	2003-10-31	Pasteur Institut	Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique
US7090848B1 (en) *	1998-08-04	2006-08-15	Henry M. Jackson Foundation For The Advancement Of Military Medicine	HIV-1 envelope protein associated with a broadly reactive neutralizing antibody response
US6911527B1 (en)	1999-01-11	2005-06-28	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	HIV related peptides
WO2000042068A2 (en) *	1999-01-11	2000-07-20	The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Hiv related peptides
US8022040B2 (en) *	2004-11-29	2011-09-20	The Regents Of The University Of California	Hydroxyapatite-binding peptides for bone growth and inhibition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4695624A (en) *	1984-05-10	1987-09-22	Merck & Co., Inc.	Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
NZ214503A (en) *	1984-12-20	1990-02-26	Merck & Co Inc	Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates
CA1339363C (en) *	1987-05-01	1997-08-26	Alan Ray Flesher	Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
NL8702403A (nl) *	1987-10-09	1989-05-01	Stichting Centr Diergeneeskund	Oligopeptiden en gebruik daarvan voor diagnostische en vaccinatiedoeleinden voor aids en arc.
EP0339504A3 (en) *	1988-04-26	1990-09-12	The Du Pont Merck Pharmaceutical Company	Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
AU640619B2 (en) *	1988-10-03	1993-09-02	Repligen Corporation	Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
IL94558A0 (en) *	1989-06-06	1991-03-10	Merck & Co Inc	Conjugate immunogen for aids and vaccine and pharmaceutical compositions containing it

1991
- 1991-08-05 IL IL99077A patent/IL99077A0/xx unknown
- 1991-08-06 NZ NZ239281A patent/NZ239281A/xx unknown
- 1991-08-07 EP EP19910202025 patent/EP0471407A3/en not_active Withdrawn
- 1991-08-07 CA CA002048594A patent/CA2048594A1/en not_active Abandoned
- 1991-08-09 PT PT98633A patent/PT98633A/pt not_active Application Discontinuation
- 1991-08-12 IE IE284691A patent/IE912846A1/en unknown
- 1991-08-12 KR KR1019910013847A patent/KR920004422A/ko not_active Application Discontinuation
- 1991-08-12 AU AU81777/91A patent/AU642751B2/en not_active Ceased
- 1991-08-12 NO NO91913127A patent/NO913127L/no unknown
- 1991-08-12 FI FI913817A patent/FI913817A/fi not_active Application Discontinuation
- 1991-08-13 JP JP3202789A patent/JPH06321808A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
EP0471407A3 (en)	1993-05-12
PT98633A (pt)	1992-06-30
IE912846A1 (en)	1992-02-26
KR920004422A (ko)	1992-03-27
IL99077A0 (en)	1992-07-15
CA2048594A1 (en)	1992-02-14
NO913127D0 (no)	1991-08-12
AU8177791A (en)	1992-02-20
JPH06321808A (ja)	1994-11-22
FI913817A0 (fi)	1991-08-12
FI913817A (fi)	1992-02-14
AU642751B2 (en)	1993-10-28
EP0471407A2 (en)	1992-02-19
NZ239281A (en)	1993-09-27

Publication	Publication Date	Title
NO912848D0 (no)	1991-07-19	Substituerte azoler, fremgangsmaate for fremstilling deravog anvendelse av forbindelsene.
NO912051D0 (no)	1991-05-28	Fremgangsmaate for fremstilling av azolderivater.
NO905285D0 (no)	1990-12-06	Fremgangsmaate for fremstilling av skumstoffer.
NO883475D0 (no)	1988-08-04	Fremgangsmaate for fremstilling av antibakterielle kinoloner.
NO912346D0 (no)	1991-06-17	Fremgangsmaate for fremstilling av aminobenzodiazepiner.
NO912808D0 (no)	1991-07-18	Framgangsmaate for framstilling av silisium-metall.
NO911122D0 (no)	1991-03-20	Fremgangsmaate for fremstilling av antihyperkolesterolemiske midler.
NO157805C (no)	1988-05-25	Fremgangsmaate for fremstilling av et preparat for behandling av urinveisinfeksjoner.
NO882295D0 (no)	1988-05-25	Fremgangsmaate for fremstilling av paryledimeren.
NO912242L (no)	1991-12-13	Sorpsjon av trialkylarsiner.
NO913127D0 (no)	1991-08-12	Fremgangsmaate for fremstilling av noeytraliserende hiv-determinanter.
NO911606L (no)	1991-10-25	Fremgangsmaate for fremstilling av glycidylazidpolymer.
NO912797L (no)	1992-01-20	Analogifremgangsmaate for fremstilling av terapeutisk virksomme karbostirilderivater.
NO913360L (no)	1992-03-02	Fremgangsmaate for fremstilling av syntesegass.
NO913692D0 (no)	1991-09-19	Fremgangsmaate for fremstilling av karbapenemforbindelser.
NO905453D0 (no)	1990-12-18	Fremgangsmaate ved fremstilling av klordioksyd.
NO885200L (no)	1989-05-24	Fremgangsmaate for fremstilling av pro-legemidler.
FI900273A (fi)	1991-07-18	Anordning foer utfaellning av fibermassa.
NO910556D0 (no)	1991-02-12	Fremgangsmaate for fremstilling av 7-amino-3-metoksymetyl-cef-3-em-4-karboksylsyre.
NO901315D0 (no)	1990-03-21	Fremgangsmaate for fremstilling av modifisert pe40.
TR24863A (tr)	1992-07-01	ALKALIFOSFAT CÖZELTILERININ üRETILMESINE MAHSUS USUL.
NO903796L (no)	1992-03-02	Fremgangsmaate for fremstilling av optisk aktive epoksyder.
FI913414A0 (fi)	1991-07-15	Foerfarande foer framstaellning av 2-hydroxi-3-halogen-5-nitropyridiner.
NO914563D0 (no)	1991-11-21	Fremgangsmaate for fremstilling av 3h-puriner
NO902583D0 (no)	1990-06-11	Fremgangsmaate for fremstilling av haandloeper for kurvet trapp.